Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retrospective Observational Study to Define HBsAg Loss With or Without Seroconversion to antiHBs in Patients With Chronic Hepatitis by B Virus Treated With Nucleoside/Nucleotide Analogs

NCT02005146 is registered in ClinicalTrials.gov with Fundación Pública Andaluza Progreso y Salud as lead sponsor.

NCT NCT02005146
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02005146 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retrospective Observational Study to Define HBsAg Loss With or Without Seroconversion to antiHBs in Patients With Chronic Hepatitis by B Virus Treated With Nucleoside/Nucleotide Analogs
Lead sponsor
Fundación Pública Andaluza Progreso y Salud
Phase
Observational
Overall status
Completed
Start date
December 31, 2013
Completion date
December 31, 2014
Enrollment
86 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis b treated with nucleoside/nucleotide analogues